VRDN viridiantherapeutics.com: Expected earnings per share growth for next year

Public company logo of Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics (VRDN) is implementing ESG principles by reducing energy consumption and plastic waste in its laboratories. Shifting analyst expectations for EPS growth in year n+1 reflect forecast dynamics where the 41.70 level represents the current value. The asset serves as a defensive tool due to stable demand for ophthalmology. Meanwhile, drug synthesis is accelerating through the application of artificial intelligence algorithms.

VRDN: Viridian Pharma Consensus forecast of earnings per share growth for next year 07/04/2022 - 11/16/2026

VRDN (Viridian Therapeutics, Inc.): analytical breakdowns and indicator data

General company analysis:viridiantherapeutics.com, VRDN
Finished products of viridiantherapeutics.com

This indicator reflects the analysts' consensus estimate regarding the growth rate of earnings per share (EPS) for the next fiscal period, allowing for the identification of a fundamental overvaluation or undervaluation of the asset. By analyzing the forward EPS growth forecast, an investor can compare market expectations with the management competencies of Viridian Therapeutics (VRDN) regarding the acceleration of clinical trials and the transparency of their reporting.

Competitor analysis

ALC (Alcon Corp) - Earnings growth forecast for next year|Bausch + Lomb Corporation (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GKOS|Earnings growth forecast for next year Apellis Pharmaceuticals, Inc. (APLS)|Earnings growth forecast for next year BLTE (Belite Bio)|OCUL - Expected earnings per share growth for next year|HROW - Net earnings per share growth forecast for next year|LENZ (LENZ Therapeutics) - Projected earnings per share growth rate for next year|Oculis (OCS) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year EYPT (EyePoint Pharmaceuticals Inc)|Net earnings per share growth forecast for next year Kodiak Sciences Inc|Expected net earnings per share growth next year aldeyra.com ALDX|Earnings growth forecast for next year KALA|IRD - Expected net earnings per share growth next year|Earnings growth forecast for next year OKYO (OKYO Pharma Limited)|ADVM - Expected earnings per share growth for next year|OTLK: Expected earnings per share growth for next year|CLSD (Clearside) - Projected earnings per share growth rate for next year|NBY: Earnings growth forecast for next year|Kiora Pharma (KPRX) - Earnings growth forecast for next year|ALIM (alimerasciences.com) - Earnings growth forecast for next year|eyenovia.com (EYEN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GHSI|OCUP (Ocuphire) - Expected earnings per share trend next year|Earnings growth forecast for next year OPT (Opthea Ltd)